生命科学资讯

Takeda inks $1.7B AI drug discovery deal with Iambic Therapeutics

Lilly buys Orna in $2.4B deal to enter in vivo CAR-T arena

Thermo Fisher Scientific Inc files for four-part senior notes offering size not disclosed - marketscreener.com

Lilly joins in vivo CAR-T sprint with $2.4B Orna acquisition

Galux raises $29M Series B; CSL teams up with Memo

My path to Illumina - Illumina

Biggest gainers and losers for Feb. 2-6, 2026

BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation - Becton Dickinson

#ACTRIMS26: Roche’s MS drug fenebrutinib beats Ocrevus, cutting risk of disability progression by 12%

Takeda, Iambic sign multiyear R&D deal for AI drug discovery

New diagnostics define drug targets for Alzheimer’s, Parkinson’s and beyond

Venenum Biodesign discloses new MOGAT2 inhibitors

Korean researchers report new HER1/HER2 mutant inhibitors

Hansoh Pharma and Hansoh Bio synthesize new muscarinic M4 receptor agonists

Takeda, Iambic partner in latest pharma AI push

Waters Corporation (WAT) Exceeds Q4 Expectations and Provides Op - GuruFocus

Novo Nordisk sues Hims over Wegovy patent infringement, considers seeking 'hundreds of millions' in damages

Waters Corporation Reports Fourth Quarter and Full-Year 2025 Financial Results - TradingView

Lilly, Innovent pen $8.8B oncology, immunology collab that 'moves beyond traditional licensing'

Small and mighty: single-domain antibodies pack a biological punch